AL
ARRY

Airain Ltd’s Array Biopharma Inc ARRY Stock Holding History

Airain Ltd’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$325K Sell
38,866
-60,832
-61% -$497K 0.01% 640
2017
Q1 		$891K Buy
99,698
+8,917
+10% +$94.9K 0.04% 372
2016
Q4 		$798K Buy
+90,781
New +$668K 0.06% 277
2016
Q3 		– Sell
-91,754
Closed -$327K – 881
2016
Q2 		$327K Sell
91,754
-42,087
-31% -$137K 0.02% 509
2016
Q1 		$395K Sell
133,841
-75,835
-36% -$227K 0.03% 506
2015
Q4 		$885K Buy
+209,676
New +$957K 0.06% 331
2015
Q3 		– Sell
-146,834
Closed -$1.06M – 1158
2015
Q2 		$1.06M Buy
146,834
+84,341
+135% +$622K 0.06% 340
2015
Q1 		$461K Sell
62,493
-137,268
-69% -$977K 0.03% 512
2014
Q4 		$945K Buy
+199,761
New +$790K 0.08% 283

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Airain Ltd's ARRY Position: Q2 2017 in Review

Airain Ltd reduced its Array Biopharma Inc (ARRY) stake by 61% in Q2 2017, selling an estimated $497K and leaving 38,866 shares worth $325K. The position accounts for 0.01% of the portfolio, ranked #640.

Airain Ltd first reported a position in ARRY in Q4 2014 and has held it in 9 quarters since. The position peaked at $1.06M in Q2 2015. 182 funds tracked by Wall St. Rank hold ARRY as of Q2 2017.

  • Airain Ltd held 38,866 shares of Array Biopharma Inc worth $325K as of Q2 2017.
  • Airain Ltd sold 60,832 Array Biopharma Inc shares in Q2 2017, an estimated $497K.
  • Array Biopharma Inc made up 0.01% of Airain Ltd's portfolio in Q2 2017, its #640 holding.
  • Airain Ltd first reported a position in Array Biopharma Inc in Q4 2014 and has held it in 9 quarters since.
  • Airain Ltd's Array Biopharma Inc position peaked at $1.06M in Q2 2015.
  • 182 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.